A SCREENING RESEARCH OF PLASMA BLOOD DONORS FOR MARKERS PARVOVIRUS INFECTION

Parvovirus B19 (PV B19) replicates predominantly in progenitor cells of human erythrocytes and is transmitted by an airborne, vertical through and through blood or infected tissues. At-risk are pregnant women, people with immunodeficiency of different nature and individuals who need blood transfusio...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Anastassia Ya. Antipova, O. N. Nikishov, I. V. Khamitova, A. V. Semenov, M. A. Bichurina, A. A. Kuzin, I. N. Lavrentieva
Formato:	article
Lenguaje:	RU
Publicado:	Sankt-Peterburg : NIIÈM imeni Pastera 2015
Materias:	parvovirus b19 donor plasma of blood dna igg safety Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/e1f1a33ca8f743cd9307e518d08fa694
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e1f1a33ca8f743cd9307e518d08fa694
record_format	dspace
spelling	oai:doaj.org-article:e1f1a33ca8f743cd9307e518d08fa6942021-11-22T07:09:47ZA SCREENING RESEARCH OF PLASMA BLOOD DONORS FOR MARKERS PARVOVIRUS INFECTION2220-76192313-739810.15789/2220-7619-2015-2-171-174https://doaj.org/article/e1f1a33ca8f743cd9307e518d08fa6942015-06-01T00:00:00Zhttps://www.iimmun.ru/iimm/article/view/299https://doaj.org/toc/2220-7619https://doaj.org/toc/2313-7398Parvovirus B19 (PV B19) replicates predominantly in progenitor cells of human erythrocytes and is transmitted by an airborne, vertical through and through blood or infected tissues. At-risk are pregnant women, people with immunodeficiency of different nature and individuals who need blood transfusions or organ transplantation. The available data indicate a high risk of infection through transfusion of blood containing the DNA of parvovirus B19, with viral load 105 copies/ml and above (Hourfar M.K. et al., 2011). According to the requirements of national regulations, the production of therapeutic drugs from plasma assumes the use of raw materials, free from viruses or with minimal viral load (Filatova E.C. et al., 2011). In some foreign countries a study of donor blood for the presence of DNA PV B19 is required; in our country the need for such screening is discussed (Giburt E.B. et al., 2013). Due to the fact that parvovirus is resistant to the methods of blood products desinfection, it is especially important to assess the quality of donor blood. Objective: To investigate the prevalence of the two markers parvovirus infection (IgG and PV B19 DNA) in blood samples from one of the blood centers at St. Petersburg. Plasma samples from 100 blood donors from Military Medical Academy blood centre were tested by ELISA for the presence of IgG antibodies of parvovirus B19. Positive samples were tested by PCR for the DNA of parvovirus B19. ELISA test system recomWell Parvovirus B19 IgG (Microgen GmbH, Germany) and diagnostic kits of Federal State Institution of Science «Central research Institute for epidemiology» of Rospotrebnadzor (Moscow, Russia) which are approved for use in RF was used according to the manufacturers instructions. It was shown that 78 out of 100 donors aged 18 to 58 years had IgG-antibodies.76 positive blood plasma samples were investigated by PCR, with the 19 donors have found DNA of parvovirus B19 (25%). Viral load of one donor was 106 copies/ml. In this case, there is the high risk of infection for the recipient. Results obtained are consistent with literature data. Obviously, it is need to investigate donor blood for parvovirus B19 presence. Obvious that quantification of the DNA of parvovirus B19 in blood products is need.Anastassia Ya. AntipovaO. N. NikishovI. V. KhamitovaA. V. SemenovM. A. BichurinaA. A. KuzinI. N. LavrentievaSankt-Peterburg : NIIÈM imeni Pasteraarticleparvovirus b19donorplasma of blooddnaiggsafetyInfectious and parasitic diseasesRC109-216RUInfekciâ i Immunitet, Vol 5, Iss 2, Pp 171-174 (2015)
institution	DOAJ
collection	DOAJ
language	RU
topic	parvovirus b19 donor plasma of blood dna igg safety Infectious and parasitic diseases RC109-216
spellingShingle	parvovirus b19 donor plasma of blood dna igg safety Infectious and parasitic diseases RC109-216 Anastassia Ya. Antipova O. N. Nikishov I. V. Khamitova A. V. Semenov M. A. Bichurina A. A. Kuzin I. N. Lavrentieva A SCREENING RESEARCH OF PLASMA BLOOD DONORS FOR MARKERS PARVOVIRUS INFECTION
description	Parvovirus B19 (PV B19) replicates predominantly in progenitor cells of human erythrocytes and is transmitted by an airborne, vertical through and through blood or infected tissues. At-risk are pregnant women, people with immunodeficiency of different nature and individuals who need blood transfusions or organ transplantation. The available data indicate a high risk of infection through transfusion of blood containing the DNA of parvovirus B19, with viral load 105 copies/ml and above (Hourfar M.K. et al., 2011). According to the requirements of national regulations, the production of therapeutic drugs from plasma assumes the use of raw materials, free from viruses or with minimal viral load (Filatova E.C. et al., 2011). In some foreign countries a study of donor blood for the presence of DNA PV B19 is required; in our country the need for such screening is discussed (Giburt E.B. et al., 2013). Due to the fact that parvovirus is resistant to the methods of blood products desinfection, it is especially important to assess the quality of donor blood. Objective: To investigate the prevalence of the two markers parvovirus infection (IgG and PV B19 DNA) in blood samples from one of the blood centers at St. Petersburg. Plasma samples from 100 blood donors from Military Medical Academy blood centre were tested by ELISA for the presence of IgG antibodies of parvovirus B19. Positive samples were tested by PCR for the DNA of parvovirus B19. ELISA test system recomWell Parvovirus B19 IgG (Microgen GmbH, Germany) and diagnostic kits of Federal State Institution of Science «Central research Institute for epidemiology» of Rospotrebnadzor (Moscow, Russia) which are approved for use in RF was used according to the manufacturers instructions. It was shown that 78 out of 100 donors aged 18 to 58 years had IgG-antibodies.76 positive blood plasma samples were investigated by PCR, with the 19 donors have found DNA of parvovirus B19 (25%). Viral load of one donor was 106 copies/ml. In this case, there is the high risk of infection for the recipient. Results obtained are consistent with literature data. Obviously, it is need to investigate donor blood for parvovirus B19 presence. Obvious that quantification of the DNA of parvovirus B19 in blood products is need.
format	article
author	Anastassia Ya. Antipova O. N. Nikishov I. V. Khamitova A. V. Semenov M. A. Bichurina A. A. Kuzin I. N. Lavrentieva
author_facet	Anastassia Ya. Antipova O. N. Nikishov I. V. Khamitova A. V. Semenov M. A. Bichurina A. A. Kuzin I. N. Lavrentieva
author_sort	Anastassia Ya. Antipova
title	A SCREENING RESEARCH OF PLASMA BLOOD DONORS FOR MARKERS PARVOVIRUS INFECTION
title_short	A SCREENING RESEARCH OF PLASMA BLOOD DONORS FOR MARKERS PARVOVIRUS INFECTION
title_full	A SCREENING RESEARCH OF PLASMA BLOOD DONORS FOR MARKERS PARVOVIRUS INFECTION
title_fullStr	A SCREENING RESEARCH OF PLASMA BLOOD DONORS FOR MARKERS PARVOVIRUS INFECTION
title_full_unstemmed	A SCREENING RESEARCH OF PLASMA BLOOD DONORS FOR MARKERS PARVOVIRUS INFECTION
title_sort	screening research of plasma blood donors for markers parvovirus infection
publisher	Sankt-Peterburg : NIIÈM imeni Pastera
publishDate	2015
url	https://doaj.org/article/e1f1a33ca8f743cd9307e518d08fa694
work_keys_str_mv	AT anastassiayaantipova ascreeningresearchofplasmablooddonorsformarkersparvovirusinfection AT onnikishov ascreeningresearchofplasmablooddonorsformarkersparvovirusinfection AT ivkhamitova ascreeningresearchofplasmablooddonorsformarkersparvovirusinfection AT avsemenov ascreeningresearchofplasmablooddonorsformarkersparvovirusinfection AT mabichurina ascreeningresearchofplasmablooddonorsformarkersparvovirusinfection AT aakuzin ascreeningresearchofplasmablooddonorsformarkersparvovirusinfection AT inlavrentieva ascreeningresearchofplasmablooddonorsformarkersparvovirusinfection AT anastassiayaantipova screeningresearchofplasmablooddonorsformarkersparvovirusinfection AT onnikishov screeningresearchofplasmablooddonorsformarkersparvovirusinfection AT ivkhamitova screeningresearchofplasmablooddonorsformarkersparvovirusinfection AT avsemenov screeningresearchofplasmablooddonorsformarkersparvovirusinfection AT mabichurina screeningresearchofplasmablooddonorsformarkersparvovirusinfection AT aakuzin screeningresearchofplasmablooddonorsformarkersparvovirusinfection AT inlavrentieva screeningresearchofplasmablooddonorsformarkersparvovirusinfection
_version_	1718418075820228608

A SCREENING RESEARCH OF PLASMA BLOOD DONORS FOR MARKERS PARVOVIRUS INFECTION

Ejemplares similares